The Eisai USA Foundation, Inc. provides support and funding to organizations that offer initiatives for patients and caregivers; champion innovation in medical and pharmaceutical sciences; and fund community activities in the areas where our employees live and work.
Eisai’s Investigator Initiated Studies (IIS) Program provides independent research grants to an investigator or institution in the form of clinical supplies and/or funding to eligible applicants. IIS research grants must support scientifically compelling and innovative studies that are consistent with Eisai’s strategic research goals and therapeutic areas of focus and must address legitimate medical or scientific questions.
Eisai’s IIS program is focused on the following areas of therapeutic interest for which grant applications are currently being evaluated:
Investigator Initiated Study (IIS) research types that may be considered for funding include, but are not limited to:
The following factors are considered by the IIS Committee when determining whether a grant applicant is qualified to receive an IIS research grant:
Applications are evaluated based upon therapeutic area relevance and applicability, support of product or compound goals, scientifically compelling and innovative research that is congruent with the strategic focus for the product or compound in question, sound science, cost effectiveness and feasibility of proposal.